Kidney Cancer Treatment at Toronto General Hospital
Kidney Cancer Treatment at Toronto General Hospital provides specialist assessment and individualized treatment planning for patients diagnosed with kidney cancer. Treatment depends on the type, size, location, stage, and characteristics of the kidney tumor, as well as the patient's kidney function, overall health, and previous treatment history.
Depending on the clinical situation, treatment may include active surveillance, surgery, minimally invasive procedures, ablation, targeted therapies, immunotherapy, or other systemic cancer treatments. Complex cases may require coordinated care involving urology, oncology, radiology, pathology, and other specialists.
Price on Request
The cost of kidney cancer treatment varies according to the type and stage of cancer, diagnostic investigations, tumor characteristics, surgical complexity, medications, systemic therapies, hospital services, and follow-up requirements. The cost may also differ for patients requiring multidisciplinary or complex cancer care. International patients may have additional administrative and treatment requirements. A personalized estimate can be determined after reviewing the patient's medical records and recommended treatment plan.
Kidney cancer treatment refers to medical and surgical approaches used to manage malignant tumors originating in the kidney. The most common type in adults is renal cell carcinoma, although several other types of kidney tumors can occur.
Treatment is selected according to the tumor's characteristics and whether the cancer is confined to the kidney or has extended to nearby structures or distant organs.
Treatment may be considered for patients with:
A confirmed kidney cancer diagnosis
A suspicious kidney mass requiring specialist assessment
A localized kidney tumor
A locally advanced kidney cancer
Metastatic kidney cancer
Recurrent kidney cancer
Multiple or complex kidney tumors
A kidney tumor requiring surgical evaluation
A kidney mass that requires further diagnostic assessment
The appropriate treatment pathway is determined after detailed clinical and diagnostic evaluation.
A complete assessment may include a review of symptoms, medical history, kidney function, previous imaging, laboratory results, and biopsy or pathology findings when available.
The medical team may evaluate factors such as blood in the urine, unexplained weight changes, abdominal or flank discomfort, fatigue, or other symptoms, although kidney cancer can sometimes be identified before symptoms develop.
Imaging is an important part of evaluating kidney tumors. Depending on the clinical situation, investigations may include ultrasound, CT scans, MRI, or other appropriate imaging studies.
Imaging can help determine the size and location of a tumor and its relationship to surrounding structures. It may also provide information needed for surgical planning and staging.
Staging helps determine how far the cancer has progressed and is an important factor in treatment selection.
The assessment may consider the size and location of the primary tumor, involvement of nearby tissues or lymph nodes, and evidence of disease in other parts of the body. Additional investigations may be recommended depending on the individual case.
Partial nephrectomy involves removing the kidney tumor while preserving as much healthy kidney tissue as clinically possible.
This approach may be considered for selected localized kidney tumors, particularly when preservation of kidney function is an important consideration. Suitability depends on tumor size, location, anatomy, kidney function, and other patient-specific factors.
Radical nephrectomy involves removal of the affected kidney and may be recommended for selected kidney cancers when partial kidney removal is not considered appropriate.
The decision depends on the tumor's characteristics, location, extent of disease, kidney function, and overall medical condition.
Selected patients may be suitable for minimally invasive surgical approaches. Depending on the clinical circumstances and available expertise, minimally invasive surgery can be considered for certain kidney procedures.
The appropriate surgical technique is determined by the tumor's size and location, patient anatomy, previous abdominal surgery, overall health, and specialist assessment.
Some kidney tumors are difficult to treat because of their size, location, proximity to major blood vessels, involvement of surrounding structures, or other anatomical factors.
Complex cases may require detailed imaging, multidisciplinary assessment, and individualized surgical planning.
In selected patients with small kidney masses or specific clinical circumstances, active surveillance may be considered rather than immediate treatment.
Surveillance involves regular clinical and imaging assessments to monitor whether the tumor changes over time. The suitability of surveillance depends on tumor characteristics, patient age, overall health, kidney function, and other factors.
For selected kidney tumors, image-guided ablation may be considered. Ablation uses a specialized technique to destroy tumor tissue without removing the entire kidney.
Suitability depends on tumor size, location, anatomy, patient health, and other clinical considerations.
When kidney cancer has spread beyond the kidney, treatment may involve systemic therapies rather than surgery alone.
Depending on the cancer characteristics and previous treatment, options may include immunotherapy, targeted therapies, or other systemic approaches. Treatment is individualized according to the patient's disease and overall health.
Modern kidney cancer management may involve medications designed to stimulate the immune system or target specific biological pathways involved in cancer growth.
The choice of treatment depends on cancer type, stage, previous treatment, molecular or clinical characteristics when relevant, and the patient's overall condition.
Kidney cancer may recur after initial treatment. When recurrence is suspected, the medical team may review previous surgical and oncology records, imaging studies, laboratory findings, and the location of recurrent disease.
Treatment may involve surgery, systemic therapy, radiation in selected circumstances, surveillance, or combinations of treatments depending on the clinical situation.
Preserving kidney function can be an important consideration when planning treatment. The medical team may evaluate kidney function before and after treatment and consider the patient's existing kidney health when selecting an appropriate approach.
For selected patients, kidney-preserving surgery may be considered when clinically suitable.
When tissue is obtained through surgery or biopsy, pathological examination can help determine the tumor type and other important characteristics.
Pathology findings may contribute to staging, risk assessment, treatment planning, and follow-up recommendations.
Patients diagnosed with kidney cancer may seek a specialist second opinion before deciding on surgery, surveillance, or systemic treatment.
A second-opinion assessment can include review of imaging, pathology, laboratory results, previous treatment records, and the proposed treatment plan. This may be particularly valuable for complex tumors or situations involving multiple treatment options.
Kidney cancer may require coordinated care between multiple specialties. Depending on the patient's needs, the care team may include urologists, medical oncologists, radiation oncologists, radiologists, pathologists, and other healthcare professionals.
Multidisciplinary collaboration can help integrate diagnostic information and develop an individualized treatment strategy.
International patients seeking kidney cancer treatment may undergo a review of their medical records before treatment planning. Relevant documents may include CT or MRI reports, imaging files, pathology reports, biopsy results, blood test results, previous surgical records, oncology treatment history, and current medications.
Treatment recommendations and appointment arrangements depend on specialist assessment and applicable international patient requirements.
Specialist assessment of kidney tumors
Individualized cancer treatment planning
Evaluation of localized and advanced kidney cancer
Kidney-preserving treatment assessment when appropriate
Access to surgical and oncology expertise
Review of complex and recurrent cases
Multidisciplinary cancer care
Detailed imaging and pathology review
Support for second-opinion evaluations
Coordinated care for eligible international patients
Toronto General Hospital is part of University Health Network and operates within a major academic healthcare environment. Patients with complex kidney cancer may benefit from specialist expertise, advanced diagnostic resources, multidisciplinary collaboration, and individualized treatment planning.
Kidney cancer treatment varies considerably between patients. The appropriate approach depends on the tumor's characteristics, cancer stage, kidney function, general health, and previous treatment history.
The total cost of kidney cancer treatment depends on the patient's diagnosis and recommended treatment pathway. Costs may include specialist consultations, imaging, laboratory investigations, biopsy or pathology review, surgery, anesthesia, hospital services, medications, systemic cancer treatments, and follow-up care.
Price on Request is provided because each kidney cancer case requires an individualized treatment plan and may involve different combinations of medical and surgical services.
Depending on the patient's condition, treatment may include active surveillance, partial nephrectomy, radical nephrectomy, ablation, systemic therapies, immunotherapy, targeted treatments, or combinations of these approaches.
In selected patients, partial nephrectomy or other kidney-preserving approaches may be considered. Suitability depends on the tumor's size, location, anatomy, kidney function, and overall medical condition.
Doctors consider the type and stage of cancer, tumor size and location, imaging and pathology findings, kidney function, overall health, previous treatments, and other individual factors when developing a treatment plan.
Yes. A specialist second opinion can include review of imaging, pathology, biopsy results, previous treatment records, and the proposed treatment plan. This may help patients understand their diagnosis and available treatment options.
There is no single fixed price because treatment requirements vary between patients. The final cost depends on investigations, surgery or other treatments, hospital services, medications, and follow-up care, so the price is provided on request.
Product Name: Kidney Cancer Treatment at Toronto General Hospital
Hospital: Toronto General Hospital
Brand: Toronto General Hospital
Country: Canada
Specialty: Urology
Service Type: Kidney Cancer Treatment
Customer-Facing Price: Price on Request
International Patients: Subject to applicable eligibility and appointment requirements
Location: Toronto, Ontario, Canada
Frequently Bought Together
Products from this Seller
View All
Subscribe our newsletter for coupon, offer and exciting promotional discount..
Share with Friends
Trading is more effective when you share products with friends!Share you link
Share to